ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
53 announcements
Dhampur Bio Organics has scheduled a board meeting for 14 November 2026 to approve audited results and a share buyback proposal. The trading window stays closed until 16 November 2026.
Dhampur Bio Organics' VP Financial Planning and Analysis, Harmeet Singh, resigned, effective October 31, 2026. It is a senior management departure.
Dhampur Bio Organics Limited announced the cessation of Mr. Surendra Rai Kapur as Cost Auditor due to his demise, effective October 19, 2026.
Dhampur Bio Organics entered a technology licensing agreement with Planetary SA to produce Mycoprotein, with future plans for a joint venture and offtake agreement.
Dhampur Bio Organics Ltd. executed a Technology Licensing Agreement with Planetary SA to produce Mycoprotein in India, introducing a new business segment and revenue stream.
The company submitted the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Dhampur Bio Organics has promoted Mr. Pankaj Agarwal and Mr. Vinamra Agarwal to Vice President roles. These leadership changes are effective from October 01, 2026.
Promoter group entity Sonitron Limited acquired 85,000 shares of Dhampur Bio Organics Ltd via open market purchases for an aggregate value of ₹1.04 Crore.
Sonitron Limited, a promoter group entity, acquired 10,000 equity shares of Dhampur Bio Organics Limited through the open market. This acquisition increased the promoter's stake by 0.015%.
Promoter Group entity Sonitron Limited acquired 10,000 shares of Dhampur Bio Organics Ltd via market purchase for Rs.0.11 Crore, increasing their stake to 17.37%.
DBO Employee Welfare Trust bought 10,000 Dhampur Bio Organics shares on NSE for ₹0.11 Crore. Routine ESOP trust inventory purchase.
DBO Employee Welfare Trust acquired 20,000 equity shares of Dhampur Bio Organics Ltd via market purchase on September 17 and 18, 2026.
DBO Employee Welfare Trust purchased 25,000 equity shares via market route on September 15-16, 2026. The total consideration for these acquisitions is ₹0.29 Crore.
DBO Employee Welfare Trust acquired 5,000 equity shares of Dhampur Bio Organics Ltd via market purchase for Rs. 0.06 Crore.
DBO Employee Welfare Trust purchased 5,000 equity shares of Dhampur Bio Organics Ltd from the market for ₹0.07 Crore on September 3, 2026.
CARE Ratings has reaffirmed the credit rating for Dhampur Bio Organics Limited's bank facilities, assigning CARE BBB+ (Positive) for long-term and CARE A2 for short-term facilities.
Dhampur Bio Organics Ltd has remitted the final dividend of ₹1.50 per equity share for the financial year 2025-26 to its shareholders.
Sonitron Limited, a promoter group entity, acquired 40,000 equity shares of Dhampur Bio Organics Limited. The open-market purchase increased its total stake from 17.29% to 17.35%.
Mr. Lalit Dalal has resigned as Vice President - Finance & Accounts of Dhampur Bio Organics Ltd, effective from the close of business hours on July 31, 2026.
Sonitron Ltd increased its stake in Dhampur Bio Organics Ltd via open market purchases. The promoter holding rose from 17.27% to 17.29%.
Dhampur Bio Organics Limited held its 6th Annual General Meeting on July 24, 2026, to conduct business, including dividend declaration and various appointments.
Dhampur Bio Organics Limited's Board met to consider a dividend declaration. The Board decided not to declare any dividend at this time.
Dhampur Bio Organics reported Q1FY27 Revenue of ₹553.88 Cr (up 4.51% YoY) but a loss from continued operations of ₹12.14 Cr. Strategic focus is transitioning to value-added sugar, spirits, and bio-energy.
Dhampur Bio Organics re-appointed Grant Thornton Bharat LLP as Internal Auditor for 12 months. The decision was finalized during a board meeting on July 14, 2026.
Dhampur Bio Organics completed the acquisition of a 74% stake in DBION Private Limited for Rs. 74,000. DBION is now a subsidiary and joint venture entity.
Dhampur Bio Organics scheduled a board meeting for July 14, 2026. The board will consider Q1 results and a proposal for interim dividend declaration.
Dhampur Bio Organics released its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's ESG performance and operational disclosures.
Dhampur Bio Organics Ltd filed its FY 2025-26 Annual Report. The 6th AGM is slated for July 24, 2026.
Dhampur Bio Organics Ltd convenes its 6th AGM on July 24, 2026 via video conference. The meeting will declare a 15% final dividend of Rs 1.50 per share.
Dhampur Bio Organics Ltd announced the resignation of Vice President – Operations, Mr. Santosh Mani, effective June 30, 2026. The company filed the notice under SEBI Regulation 30.